RESUMO

BACKGROUND: Constipation is the main symptom of acquired chagasic megacolon. However, a number of patients with Chagas disease without colon involvement also have the same complain. This study evaluated the role of small bowel in constipated patients with Chagas disease with and without megacolon. METHODS: Orocecal transit time (OCTT) and oral glucose tolerance test (OGTT) in constipated non-chagasic and chagasic patients with and without megacolon were performed. One hundred fifteen patients were included in this study and were divided into two groups based on the presence or absence of constipation, which is defined as at least 7 days without bowel movements for more than 1 year. These two groups were further divided into three subgroups based on the serology test results for Trypanosoma cruzi and the presence and absence of megacolon on barium enema. All patients were subjected to OCTT and OGTT. RESULTS: Among 70 constipated patients, 64.3% had OCTT longer than 120 min, higher than the non-constipated patients (31.1%, P < 0.000). The proportion of patients within the three subgroups in the non-constipated group was not different from each other (P = 0.345). Among the constipated subgroup, 94.44% of the chagasic megacolon subgroup had OCTT longer than 120 min, higher than the other two subgroups (P = 0.005). Chagas patients with constipation, without or without megacolon, showed higher blood glucose levels at 30, 60, and 90 min after oral ingestion of 70 g glucose than normal subjects with or without constipation. CONCLUSIONS: Constipated, either non-chagasic or chagasic, patients have a prolonged OCTT. This result suggests that slow small bowel transit may be a significant factor for constipation.

RESUMO

OBJECTIVE: to report clinical and pathological features of patients with colorectal cancer diagnosed during emergency abdominal surgery. METHODS: records of 107 patients operated between 2006 and 2010 were reviewed. RESULTS: there were 58 women and 49 men with mean age of 59.8 years. The most frequent symptoms were: abdominal pain (97.2%), no bowel movements (81.3%), vomiting (76.6%), and anorexia (40.2%). Patients were divided into five groups: obstructive acute abdomen (n = 68), obstructive acute perforation (n = 21), obstructive acute inflammation (n = 13), abdominal sepsis (n = 3), and severe gastrointestinal bleeding (n = 2). Tumors were located in the rectosigmoid (51.4%), transverse colon (19.6%), ascendent colon (12.1%), descendent colon (11.2%), and 5.6% of the cases presented association of two colon tumors (synchronic tumors). The surgical treatment was: tumor resection with colostomy (85%), tumor resection with primary anastomosis (10.3%), and colostomy without tumor resection (4.7%). Immediate mortality occurred in 33.4% of the patients. Bivariate analysis of sex, tumor location and stage showed no relation to death (p > 0.05%). CONCLUSIONS: colorectal cancer may be the cause of colon obstruction or perfuration in patients with nonspecific colonic complaints. Despite the high mortality rate, resection of tumor is feasible in most patients. (AU)

OBJETIVO: analisar os aspectos clinicos e patológicos de pacientes operados de cancer colorretal diagnosticados durante operações abdominais de urgencia. MÉTODOS: foram estudados os prontuários de 107 pacientes operados entre 2006 e 2010. Resultados: Foram incluidos 58 mulheres e 49 homens com idade media de 59,8 anos. Os sintomas mais frequentes foram: dor abdominal (97,2%), parade de eliminação de gases e fezes (81,3%), vomitos (76,6%) e anorexia (40,2%). Os pacientes foram divididos em cinco grupos: abdomen agudo obstrutivo (68), abdomen agudo perfurativo (21), abdomen agudo inflamatorio (13), sepsis abdominal (3) e hemorragia digestive baixa (2). Os tumores localizavam-se no rectossigmoide (51,4%), colon transverso (19,6%), colon ascendente (12,1%), colon descendente (11,2%) e 5,6% dos pacientes apresentavam tumors sincronicos. O tratamento cirurgico foi: colectomia com colostomy (85%), colectomia com anastomose primaria (10,3%) e colostomia sem ressecçao do tumor (4,7%). Mortalidade immediate ocorreu em 33,4% dos pacientes. Analise bivariate de sexo, localização do tumor e estadio não foi relacionada a mortalidade (P > 0,05%). CONCLUSÕES: o cancer colorretal pode ser a causa de obstrução colonica ou perfuração in pacientes com queixas inespecificas. A despeito da alta taxa de mortalidade, a ressecção do tumor pode ser realizada na maioria dos pacientes. (AU)

Assuntos

RESUMO

CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome patients are still unknown. OBJECTIVE: To observe the effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients. METHODS: Based on Rome III criteria, 61 irritable bowel syndrome with diarrhea patients (18 years old or more) were included in the evaluation. Patients were divided into two groups: postinfectious irritable bowel syndrome group, with 18 patients medicated with mesalazine 800 mg 3 times a day for 30 days; noninfective irritable bowel syndrome group, with 43 patients medicated with mesalazine 800 mg 3 times a day for 30 days. Symptom evaluations at baseline and after treatment were performed by means of a four-point Likert scale including stool frequency, stool form and consistency (Bristol Stool Scale), abdominal pain and distension (maximum score: 16; minimum score: 4). RESULTS: Postinfectious irritable bowel syndrome group presented a statistically significant reduction of the total symptom score (P<0.0001). The stool frequency was significantly reduced (P<0.0001), and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distension were significantly reduced (P<0.0001). Noninfective irritable bowel syndrome group presented a statistically significant reduction of total symptom score (P<0.0001). Also, the stool frequency was significantly reduced (P<0.0001) and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distention were significantly reduced (P<0.0001). There was no statistical difference between postinfectious irritable bowel syndrome group and noninfective irritable bowel syndrome group on total symptom score results at 30th day of therapy with mesalazine 800 mg 3 times a day. (P = 0.13). CONCLUSION: Mesalazine reduced key symptoms of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients.

Assuntos

RESUMO

CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome patients are still unknown. OBJECTIVE: To observe the effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients. METHODS: Based on Rome III criteria, 61 irritable bowel syndrome with diarrhea patients (18 years old or more) were included in the evaluation. Patients were divided into two groups: postinfectious irritable bowel syndrome group, with 18 patients medicated with mesalazine 800 mg 3 times a day for 30 days; noninfective irritable bowel syndrome group, with 43 patients medicated with mesalazine 800 mg 3 times a day for 30 days. Symptom evaluations at baseline and after treatment were performed by means of a four-point Likert scale including stool frequency, stool form and consistency (Bristol Stool Scale), abdominal pain and distension (maximum score: 16; minimum score: 4). RESULTS: Postinfectious irritable bowel syndrome group presented a statistically significant reduction of the total symptom score (P<0.0001). The stool frequency was significantly reduced (P<0.0001), and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distension were significantly reduced (P<0.0001). Noninfective irritable bowel syndrome group presented a statistically significant reduction of total symptom score (P<0.0001). Also, the stool frequency was significantly reduced (P<0.0001) and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distention were significantly reduced (P<0.0001). There was no statistical difference between postinfectious irritable bowel syndrome group and noninfective irritable bowel syndrome group on total symptom score results at 30th day of therapy with mesalazine 800 mg 3 times a day. (P = 0.13). CONCLUSION: Mesalazine reduced key symptoms of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients.

CONTEXTO: Estudos recentes sustentam a hipótese que a síndrome do intestino irritável pós-infecciosa e alguns pacientes com síndrome do intestino irritável mostram sinais menores de inflamação persistente da mucosa. A mesalazina tem propriedades anti-inflamatórias intestinais, incluindo a inibição da ciclooxigenase e das prostaglandinas. Os efeitos da mesalazina na síndrome do intestino irritável pós-infecciosa e em pacientes com síndrome do intestino irritável não-infecciosa ainda são desconhecidos. OBJETIVO- Observar os efeitos da mesalazina em pacientes com síndrome do intestino irritável pós-infecciosa e síndrome do intestino irritável com diarréia não-infecciosa. MÉTODOS: Com base nos critérios de Roma III, 61 pacientes síndrome do intestino irritável acompanhado de diarréia (18 anos ou mais de idade) foram incluídos na avaliação. Os pacientes foram divididos em dois grupos: grupo síndrome do intestino irritável pós-infecciosa, com 18 pacientes medicados com mesalazina 800 mg 3 vezes ao dia por 30 dias; grupo síndrome do intestino irritável não-infecciosa, com 43 pacientes medicados com mesalazina 800 mg 3 vezes ao dia por 30 dias. Avaliações dos sintomas no início e após o tratamento foram realizadas por meio de uma escala Likert de 4 pontos, incluindo a frequência das evacuações, forma e consistência das fezes (Bristol Stool Scale), dor e distensão abdominal (pontuação máxima: 16; pontuação mínima: 4). RESULTADOS: O grupo síndrome do intestino irritável pós-infecciosa apresentou redução estatisticamente significante do escore total de sintomas (P<0,0001). A frequência de evacuações foi significativamente reduzida (P<0,0001) e a consistência das fezes melhoraram (P<0,0001). Dor abdominal (P<0,0001) e distensão abdominal foram significativamente reduzidas (P<0,0001). O grupo síndrome do intestino irritável não-infecciosa apresentou redução estatisticamente significante do escore total de sintomas (P<0,0001). Além disso, a frequência de fezes foi significativamente reduzida (P<0,0001) e a consistência das fezes melhoraram (P<0,0001). Dor abdominal (P<0,0001) e distensão abdominal foram significativamente reduzidas (P<0,0001). Não houve diferença estatística entre o grupo síndrome do intestino irritável pós-infecciosa e o grupo síndrome do intestino irritável não-infecciosa sobre os resultados da pontuação total dos sintomas em 30 dias de terapia com mesalazina 800 mg 3 vezes ao dia (P= 0,13). CONCLUSÃO: O uso de mesalazina reduziu os principais sintomas da síndrome do intestino irritável pós-infecciosa e da síndrome do intestino irritável com diarréia não-infecciosa.

Assuntos

RESUMO

OBJETIVO: Avaliar a função pulmonar pós-colecistectomias laparoscópicas. MÉTODOS: Estudo prospectivo, onde se avaliaram espirometrias pós-operatórias de 15 pacientes submetidas à colecistectomias laparoscópicas por meio de um tempo anestésico-cirúrgico abreviado. Os dados pós-operatórios foram comparados aos pré-operatórios RESULTADOS: Existiram diferenças significativas para as variáveis Capacidade Vital Forçada (p=0,020) e Volume Expiratório Forçado no 1º segundo (p=0,022) no pré e pós-operatório imediato, indicando distúrbios ventilatórios restritivos. CONCLUSÃO: Foram observados distúrbios ventilatórios restritivos leves pós-colecistectomias laparoscópicas, com rápida recuperação da função pulmonar, o que pode diminuir a morbidade pulmonar pós-operatória.

OBJECTIVE: To evaluate pulmonary function after laparoscopic cholecystectomies. MEHTODS: Prospective study, in which the post-operative spirometries of 15 patients who underwent laparoscopic cholecystectomies with abbreviated anesthetic-surgical time were analyzed. RESULTS: Significant differences existed for the Forced Vital Capacity variable (p=0,020) and Forced Expiratory Volume in the first second (p=0,022) between pre- and immediate post-operative, indicating restrictive ventilatory disturbances. CONLCUSION: Light restrictive laparoscopic post-cholecystectomy ventilatory disturbances were observed, with rapid recovery of pulmonary function, which may lower post-operative pulmonary morbidity.

Assuntos

RESUMO

OBJETIVO: Avaliar a função pulmonar pós-colecistectomias subcostais abertas de pacientes sob ação da morfina no pós-operatório imediato. MÉTODOS: Tratou-se de um estudo prospectivo, onde se avaliaram espirometrias pós-operatórias de 15 pacientes submetidas à colecistectomias abertas subcostais, que receberam dose única de morfina peridural na anestesia. Os dados pós-operatórios foram comparados aos pré-operatórios pelo teste t-Student emparelhado. Um valor de p < 0,05 foi considerado estatisticamente significativo. RESULTADOS: Existiram diferenças significativas para as variáveis Capacidade Vital Forçada (p = 0,007) e Volume Expiratório Forçado no 1º segundo (p = 0,008) no pré e pós-operatório imediato, indicando distúrbios ventilatórios restritivos. Todas as pacientes apresentaram espirometrias normais no 3º dia de pós-operatório. CONCLUSÃO: Mesmo sob ação analgesia da morfina peridural, no pós-operatória imediato, foram observados distúrbios ventilatórios restritivos leves pós-colecistectomias subcostais abertas. Contudo, observou-se uma rápida recuperação da função pulmonar, o que pode diminuir a morbidade pulmonar pós-operatória.

OBJECTIVE: To evaluate pulmonary function after open subcostal cholecystecomy under action of the morphine in the immediate post-operative. METHODS: This was a prospective study, in which the post-operative spirometries of fifteen patients who underwent open subcostal cholecystectomies which received peridural morphine anesthesia. Post- and pre-operative data were compared using a paired student-t test. A value of p < 0,05 was considered statistically significant. RESULTS: Significant differences existed for the Forced Vital Capacity variable (p = 0,007) and Forced Expiratory Volume in the first second (p = 0,008) between pre- and immediate post-operative, indicating restrictive ventilatory disturbances. All of the patients presented normal espirometries in the third day of post-operative. CONCLUSION: Even under action morphine peridural analgesia, in the immediate post-operative, light restrictive post-cholecystectomy ventilatory disturbances were observed. However, it was observed abbreviated recovery of pulmonary function, which may lower post-operative pulmonary morbidity.

Assuntos

RESUMO

INTRODUÇÃO: Operações, principalmente de abdome superior, cursam no pós-operatório com hipoxemia e distúrbios ventilatórios restritivos. O objetivos da presente revisão foram: a) fazer retrospecto histórico das técnicas espirométricas e da avaliação laboratorial da hipoxemia, por meio da pressão arterial de oxigênio (PaO2) e, b) rever os principais fatores responsáveis pelas alterações da função pulmonar pós-operatória.MÉTODOS: Fez-se revisão histórica sobre os principais aspectos espirométricos e da medida da PaO2, correlacionando esses exames como aferidores da função pulmonar, após operações abdominais.CONCLUSÕES: Operações em andar superior do abdome podem cursar com hipoxemia e distúrbios ventilatórios restritivos, cuja principal causa é a disfunção diafragmática, que pode ser minimizada por meio de laparoscopia e um eficaz tratamento da dor pós-operatória.

INTRODUCTION: Operations, particularly those of the upper abdomen, can be accompanied by hypoxemia and restrictive ventilatory disturbances. The objectives of the present review were: a) to provide a retrospective of spirometric techniques and laboratory assessment of hypoxemia by means of arterial oxygen pressure; b) to review the main factors responsible for alterations in postoperative pulmonary function.METHODS: A historical overview is given of the main aspects of spirometry and PaO2, measurement, considering these exams as measures of pulmonary function after abdominal operations.CONCLUSION: Operations on the upper part of the abdomen may be followed by hypoxemia and restrictive ventilatory disturbances, whose principal cause is diaphragmatic dysfunction which can be minimized by means of laparoscopy and effective post-operative pain treatment.

Assuntos

RESUMO

OBJECTIVE: To evaluate pulmonary function after open subcostal cholecystecomy under action of the morphine in the immediate post-operative. METHODS: This was a prospective study, in which the post-operative spirometries of fifteen patients who underwent open subcostal cholecystectomies which received peridural morphine anesthesia. Post- and pre-operative data were compared using a paired student-t test. A value of p < 0,05 was considered statistically significant. RESULTS: Significant differences existed for the Forced Vital Capacity variable (p = 0,007) and Forced Expiratory Volume in the first second (p = 0,008) between pre- and immediate post-operative, indicating restrictive ventilatory disturbances. All of the patients presented normal espirometries in the third day of post-operative. CONCLUSION: Even under action morphine peridural analgesia, in the immediate post-operative, light restrictive post-cholecystectomy ventilatory disturbances were observed. However, it was observed abbreviated recovery of pulmonary function, which may lower post-operative pulmonary morbidity.

Assuntos

RESUMO

OBJECTIVE: To evaluate pulmonary function after laparoscopic cholecystectomies. METHODS: Prospective study, in which the post-operative spirometries of 15 patients who underwent laparoscopic cholecystectomies with abbreviated anesthetic-surgical time were analyzed. RESULTS: Significant differences existed for the Forced Vital Capacity variable (p=0,020) and Forced Expiratory Volume in the first second (p=0,022) between pre- and immediate post-operative, indicating restrictive ventilatory disturbances. CONCLUSION: Light restrictive laparoscopic post-cholecystectomy ventilatory disturbances were observed, with rapid recovery of pulmonary function, which may lower post-operative pulmonary morbidity.

Assuntos

RESUMO

OBJETIVO: Avaliar a função pulmonar pós-colecistectomias laparoscópicas e subcostais abertas. MÉTODOS: Tratou-se de um ensaio randomizado, onde se avaliaram espirometrias pós-operatórias de dois grupos, cada qual com 15 pacientes. O grupo GL foi submetido a colecistectomia laparoscópica. O grupo GA foi submetido a colecistectomia por via subcostal, por meio de mini-laparotomia e abreviado tempo anestésico-cirúrgico. As variáveis dos dois grupos foram comparadas entre si por meio da ANOVA. Entre um mesmo grupo, antes e depois das operações, utlizou-se do teste t-Student emparelhado. Um valor de p < 0,05 foi considerado estatisticamente significativo. RESULTADOS: Todas as pacientes, dos dois grupos, apresentaram distúrbios ventilatórios restritivos pós-operatórios, com normalização espirométrica mais rápida nas pacientes operadas por laparoscopia. Grupos GL X GA, no pós-operatório imediato: Capacidade vital forçada (p < 0,001) e Volume Expiratório forçado em 1 segundo (p < 0,001). CONCLUSÕES: O prejuízo pós-operatório da função pulmonar foi significativamente menor nas colecistectomias laparoscópicas do que nas abertas, mesmo por meio de mini-laparotomia e abreviado tempo anestésico-cirúrgico.

BACKGROUND: To evaluate pulmonary function after laparoscopic and subcostal cholecystectomies. METHODS: This was a randomized study, in which postoperative spirometries in two groups of fifteen patients each were evaluated. Group GL underwent laparoscopic chlecystectomies. Group GA underwent open subcostal cholecystectomies by means of mini-laparatomy, in abbreviated anesthetic-surgical time. The two groups´ variables were compared using ANOVA. Within the same group, before and after the operations, the paired Student-t test was used. A value of p < 0.05 was considered statistically significant. RESULTS: All patients from both groups presented restrictive postoperative ventilatory disturbances, with a faster spirometric normalization for those patients operated through laparoscopy. Groups GL vs. GA, in immediate post-operative: Forced Vital Capacity (p < 0.001) and Forced Expiratory Volume in one second (p < 0.001). CONCLUSION: Postoperative harm to pulmonary function was significantly less in laparoscopic than in open cholecystectomies, even with mini-laparotomies and abbreviated anesthetic-surgical time.